Core Laboratories NV
NYSE:CLB

Watchlist Manager
Core Laboratories NV Logo
Core Laboratories NV
NYSE:CLB
Watchlist
Price: 15 USD -10.98%
Market Cap: 704.3m USD
Have any thoughts about
Core Laboratories NV?
Write Note
Section:
 

Relative Value

The Relative Value of one CLB stock under the Base Case scenario is 31.8 USD. Compared to the current market price of 15 USD, Core Laboratories NV is Undervalued by 53%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLB Relative Value
Base Case
31.8 USD
Undervaluation 53%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
53
vs Industry
44
Median 3Y
1.9
Median 5Y
2
Industry
2.2
Forward
1.3
More Details
19.2
P/E
P/E
Price to Earnings
19.2
vs History
47
vs Industry
15
Median 3Y
33.8
Median 5Y
27.2
Industry
16.6
Forward
17.5
More Details
28.4
P/OCF
P/OCF
Price to OCF
28.4
vs History
34
vs Industry
5
Median 3Y
37.8
Median 5Y
35.4
Industry
10.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-165.5
Median 5Y
-64.2
Industry
13.7
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
76
vs Industry
13
Median 3Y
5.1
Median 5Y
6.6
Industry
1.6
More Details
1.7
EV/S
EV/S
Enterprise Value to Sales
1.7
vs History
53
vs Industry
46
Median 3Y
2.3
Median 5Y
2.4
Industry
3.2
Forward
1.6
More Details
7.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.7
vs History
60
vs Industry
31
Median 3Y
11.4
Median 5Y
11.4
Industry
7.1
More Details
11.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.6
vs History
60
vs Industry
12
Median 3Y
17.3
Median 5Y
17.3
Industry
11.3
Forward
10.2
More Details
14.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.8
vs History
60
vs Industry
10
Median 3Y
23.8
Median 5Y
23.8
Industry
13.2
Forward
16.1
More Details
34.3
EV/OCF
EV/OCF
Enterprise Value to OCF
34.3
vs History
34
vs Industry
5
Median 3Y
44
Median 5Y
41.4
Industry
11.1
More Details
59.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
59.9
vs History
34
vs Industry
3
Median 3Y
79.6
Median 5Y
72.2
Industry
12.2
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
55
vs Industry
26
Median 3Y
2.1
Median 5Y
2.2
Industry
1.5
More Details

Multiples Across Competitors

CLB Competitors Multiples
Core Laboratories NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
Core Laboratories NV
NYSE:CLB
702.8m USD 1.4 19.2 11.6 14.8
US
Schlumberger NV
NYSE:SLB
52.2B USD 1.4 11.7 6.8 9.6
US
Baker Hughes Co
NASDAQ:BKR
39.6B USD 1.5 17.6 9.9 13.3
US
Halliburton Co
NYSE:HAL
22.9B USD 1 9 5.5 7
LU
Tenaris SA
MIL:TEN
19.9B EUR 1.6 7.8 5.2 6.4
UK
TechnipFMC PLC
NYSE:FTI
12.2B USD 1.4 18.2 9.4 13.3
CN
CNOOC Energy Technology & Services Ltd
SSE:600968
42.3B CNY 0.8 11.7 8.7 8.7
US
Nov Inc
NYSE:NOV
5.5B USD 0.6 5.2 5.4 7.6
IT
Saipem SpA
MIL:SPM
4.9B EUR 0.4 19 4.3 8.7
US
ChampionX Corp
NASDAQ:CHX
4.9B USD 1.3 15.6 7 10.5
US
Weatherford International PLC
NASDAQ:WFRD
4.9B USD 0.9 9.2 4.3 5.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
NL
Core Laboratories NV
NYSE:CLB
Average EV/EBITDA: 7.1
11.6
34%
0.3
US
Schlumberger NV
NYSE:SLB
6.8
34%
0.2
US
B
Baker Hughes Co
NASDAQ:BKR
9.9
46%
0.2
US
Halliburton Co
NYSE:HAL
5.5
9%
0.6
LU
Tenaris SA
MIL:TEN
5.2
-38%
N/A
UK
TechnipFMC PLC
NYSE:FTI
9.4
114%
0.1
CN
CNOOC Energy Technology & Services Ltd
SSE:600968
8.7
103%
0.1
US
Nov Inc
NYSE:NOV
5.4
35%
0.2
IT
Saipem SpA
MIL:SPM
4.3
95%
0
US
ChampionX Corp
NASDAQ:CHX
7
14%
0.5
US
Weatherford International PLC
NASDAQ:WFRD
4.3
29%
0.1

See Also

Summary
CLB intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLB stock valuation using valuation multiples.
Wall Street Estimates
CLB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.